(CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bruce Eric Sands
Massachusetts General Hospital
Principal Investigator - Simon Travis
Oxford University Hospitals NHS Trust
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
58 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Santarus Clinical Investigational Site 6014
Vancouver, British Columbia, Canada
- Santarus Clinical Investigational Site 6008
Victoria, British Columbia, Canada
- Santarus Clinical Investigational Site 6004
Richmond Hill, Ontario, Canada
- Santarus Clinical Investigational Site 6006
Toronto, Ontario, Canada
- Santarus Clinical Investigational Site 6013
Longueuil, Quebec, Canada
- Santarus Clinical Investigational Site 5051
Huntsville, Alabama, United States
- Santarus Clinical Investigational Site 5088
Tucson, Arizona, United States
- Santarus Clinical Investigational Site 5044
Anaheim, California, United States
- Santarus Clinical Investigational Site 5087
Lakewood, California, United States
- Santarus Clinical Investigational Site 5033
Los Angeles, California, United States
- Santarus Clinical Investigational Site 5070
Palm Springs, California, United States
- Santarus Clinical Investigational Site 5067
San Diego, California, United States
- Santarus Clinical Investigational Site 5064
Lakewood, Colorado, United States
- Santarus Clinical Investigational Site 5089
Boynton Beach, Florida, United States
- Santarus Clinical Investigational Site 5041
Hollywood, Florida, United States
- Santarus Clinical Investigational Site 5055
New Smyrna Beach, Florida, United States
- Santarus Clinical Investigational Site 5074
Port Orange, Florida, United States
- Santarus Clinical Investigational Site 5009
Tampa, Florida, United States
- Santarus Clinical Investigational Site 5032
Tampa, Florida, United States
- Santarus Clinical Investigational Site 5047
Winter Park, Florida, United States
- Santarus Clinical Investigational Site 5003
Zephyrhills, Florida, United States
- Santarus Clinical Investigational Site 5016
Atlanta, Georgia, United States
- Santarus Clinical Investigational Site 5056
Columbus, Georgia, United States
- Santarus Clinical Investigational Site 5068
Evanston, Illinois, United States
- Santarus Clinical Investigational Site 5008
Metairie, Louisiana, United States
- Santarus Clinical Investigational Site 5090
Annapolis, Maryland, United States
- Santarus Clinical Investigational Site 5025
Baltimore, Maryland, United States
- Santarus Clinical Investigational Site 5092
Hollywood, Maryland, United States
- Santarus Clinical Investigational Site 5077
Prince Frederick, Maryland, United States
- Santarus Clinical Investigational Site 5010
Chesterfield, Michigan, United States
- Santarus Clinical Investigational Site 5006
Troy, Michigan, United States
- Santarus Clinical Investigational Site 5004
Wyoming, Michigan, United States
- Santarus Clinical Investigational Site 5005
Marlton, New Jersey, United States
- Santarus Clinical Investigational Site 5011
Great Neck, New York, United States
- Santarus Clinical Investigational Site 5101
New York, New York, United States
- Santarus Clinical Investigational Site 5020
Pittsford, New York, United States
- Santarus Clinical Investigational Site 5096
Fayetteville, North Carolina, United States
- Santarus Clinical Investigational Site 5058
Huntersville, North Carolina, United States
- Santarus Clinical Investigational Site 5091
New Bern, North Carolina, United States
- Santarus Clinical Investigational Site 5045
Cincinnati, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2008
- Primary completion
- 31 May 2011
- Completion
- 30 Jun 2011
- Last update posted
- 31 Aug 2020
- Registered enrollment
- 123
- Registry id
- NCT00801723
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.